HOME >> BIOLOGY >> NEWS
Details of promising cancer therapy shows for the first time

Visualization of action could lead to development of more potent, less toxic drugs

Scientists at Schering-Plough Research Institute are reporting what they say is the first atomic view that shows how a promising new class of cancer-fighting drugs works. The discovery may point the way to faster, better refinement of the drugs, according to the researchers. Several pharmaceutical companies are in a race to develop so-called farnesyl protein transferase (FPT) inhibitors, which incapacitate an enzyme recently found to activate many types of cancer. The drug detailed in this study is currently in clinical trials.

The findings will appear in the Journal of Medicinal Chemistry, which is published by the American Chemical Society (ACS), the world's largest scientific society. The peer-reviewed paper will be available on the ACS Web June 2 and is tentatively scheduled to appear in the journal's July 1 print edition.

FPT puts the finishing touches on a protein made under the direction of a mutated gene called ras (short for "rat sarcoma" because the gene's cancer connection was originally discovered in rats). Normally, a completed Ras protein attaches to cell membranes where it signals cells to grow, when appropriate. The mutation, which causes a single kink in the Ras protein structure, leaves it stuck in the "on" position. Out of control growth then ensues, causing cancer.

Since the gene's discovery in the early 1990s, the ras mutation has been linked to 90 percent of pancreatic cancers, 50 percent of colon cancers, and 30 percent of lung cancers. Researchers hope that by attacking FPT, instead of cell replication machinery directly, they can more specifically inhibit cancer and lessen collateral damage to normal cells.

A wave of FPT inhibitors has recently surged into clinical trials. They are one of the first types of mechanism-based anti-cancer agents targeted at a known protein molecule. While scientists had ideas about h
'"/>

Contact: Charmayne Marsh
ycm93@acs.org
202-872-4445
American Chemical Society
1-Jun-1999


Page: 1 2

Related biology news :

1. Hopkins Study Reveals Key Details On How We Get Energy
2. Schmidt-Nielsen Autobiography Details Scientific Adventures
3. Max Planck Scientists Report Molecular Details On The Interaction Of The Stress Hormone Corticotropin-Releasing Factor (CRF) And Its Receptor
4. Tobacco promising factory for biopharmaceuticals
5. Gene therapy with growth factor seems promising therapy for incurable muscle disorder ALS
6. The search for a safer smallpox vaccine: New data released on promising candidate
7. New software developed at Rensselaer predicts promising ingredients for new drugs
8. Study points to a promising new test for myelodysplasia, a blood disorder often leading to leukemia
9. Protease-inhibitor cocktail protects, increases anti-microbial action of promising new peptide
10. Researchers begin promising new trial to fight colorectal cancer
11. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 19, 2020 , ... ... SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty years. Together ... book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ...
(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, ... to announce that Eric Chen and Jessica Wong have joined the company’s leadership ... Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, ...
(Date:7/31/2020)... SAN FRANCISCO (PRWEB) , ... July 30, 2020 ... ... Therapeutics’ maturing prescription digital therapeutics product portfolio with a near term focus on ... diverse biotech and pharma commercialization experience across multiple therapeutic areas and classes. As ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... Ky. (PRWEB) , ... August 03, 2020 , ... Introducing ... products for transformative growth, , Known as MediVet Biologics since ... brand. , The new Ardent Animal Health will build on its base ...
(Date:7/31/2020)... Mass. (PRWEB) , ... July 29, 2020 , ... ... wire that can combine up to three different materials for use with CRM, ... combine up to three materials to meet specific design requirements, performance, and cost ...
(Date:7/31/2020)... ... July 30, 2020 , ... Alucio™, ... announced the release of its signature product called Beacon - a content ... other field medical professionals. , Beacon helps MSLs streamline communication and ...
(Date:7/18/2020)... DAYTON, Ohio (PRWEB) , ... July 16, 2020 ... ... clinical data solutions to aid in the early detection and prevention of high-burden ... partnership to enable US-based hospitals and healthcare organizations to utilize existing data in ...
Breaking Biology Technology:
Cached News: